These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B. Mayer RJ; Davis RB; Schiffer CA; Berg DT; Powell BL; Schulman P; Omura GA; Moore JO; McIntyre OR; Frei E N Engl J Med; 1994 Oct; 331(14):896-903. PubMed ID: 8078551 [TBL] [Abstract][Full Text] [Related]
3. Low dose cytarabine and Granulocyte / Macrophage-Colony Stimulating Factor induced long-term remission in a patient with acute myeloid leukemia in early relapse after intensive chemotherapy. Sastre JL; Ulibarrena C; Cantón I; Iglesias M; García-Torremocha S; Vázquez MO Haematologica; 2000; 85(E-letters):E09. PubMed ID: 11114824 [No Abstract] [Full Text] [Related]
4. Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission. Cassileth PA; Harrington DP; Appelbaum FR; Lazarus HM; Rowe JM; Paietta E; Willman C; Hurd DD; Bennett JM; Blume KG; Head DR; Wiernik PH N Engl J Med; 1998 Dec; 339(23):1649-56. PubMed ID: 9834301 [TBL] [Abstract][Full Text] [Related]
5. "3+7" therapy for the treatment of acute myeloid leukemia. PRO. Schiffer CA Clin Adv Hematol Oncol; 2005 Feb; 3(2):127-9. PubMed ID: 16166981 [No Abstract] [Full Text] [Related]
6. Post-remission chemotherapy for acute myeloid leukemia. Atkins CD N Engl J Med; 1995 Feb; 332(5):334; author reply 334-5. PubMed ID: 7816076 [No Abstract] [Full Text] [Related]
7. Repetitive cycles of high-dose cytarabine are effective for childhood acute myeloid leukemia: long-term outcome of the children with AML treated on two consecutive trials of Tokyo Children's Cancer Study Group. Tomizawa D; Tabuchi K; Kinoshita A; Hanada R; Kigasawa H; Tsukimoto I; Tsuchida M; Pediatr Blood Cancer; 2007 Aug; 49(2):127-32. PubMed ID: 16807916 [TBL] [Abstract][Full Text] [Related]
8. High-dose cytarabine, idarubicin, and granulocyte colony-stimulating factor remission induction therapy for previously untreated de novo and secondary adult acute myeloid leukemia. Baer MR; Christiansen NP; Frankel SR; Brunetto VL; Mrózek K; Bloomfield CD; Herzig GP Semin Oncol; 1993 Dec; 20(6 Suppl 8):6-12. PubMed ID: 7507264 [TBL] [Abstract][Full Text] [Related]
9. Fludarabine, cytarabine and topotecan (FLAT) as induction therapy for acute myeloid leukemia in the elderly: a preliminary report. Leoni F; Ciolli S; Nozzoli C; Santini V; Fanci R; Rossi Ferrini P Haematologica; 2001 Jan; 86(1):104. PubMed ID: 11146581 [No Abstract] [Full Text] [Related]
10. Phase II trial of subcutaneous recombinant human interleukin 11 with subcutaneous recombinant human granulocyte-macrophage colony stimulating factor in patients with acute myeloid leukemia (AML) receiving high-dose cytarabine during induction: ECOG 3997. Cripe LD; Rader K; Tallman MS; Gordon MS; Paietta E; Bennett J; Neuberg D; Litzow MR; O'brien TE; Rowe JM Leuk Res; 2006 Jul; 30(7):823-7. PubMed ID: 16413056 [TBL] [Abstract][Full Text] [Related]
11. Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype. Bloomfield CD; Lawrence D; Byrd JC; Carroll A; Pettenati MJ; Tantravahi R; Patil SR; Davey FR; Berg DT; Schiffer CA; Arthur DC; Mayer RJ Cancer Res; 1998 Sep; 58(18):4173-9. PubMed ID: 9751631 [TBL] [Abstract][Full Text] [Related]
12. Transplantation in first remission of acute myeloid leukemia. Burnett AK N Engl J Med; 1998 Dec; 339(23):1698-700. PubMed ID: 9834309 [No Abstract] [Full Text] [Related]
13. Is intensive treatment beneficial to elderly patients with ANLL? Harousseau JL Hematol Oncol; 1993; 11 Suppl 1():4-8. PubMed ID: 8486341 [No Abstract] [Full Text] [Related]
14. Relationship of [3H]Ara-C incorporation and response to therapy with high-dose Ara-C in AML patients: a Leukemia Intergroup study. Raza A; Gezer S; Anderson J; Lykins J; Bennett J; Browman G; Goldberg J; Larson R; Vogler R; Preisler HD Exp Hematol; 1992 Nov; 20(10):1194-200. PubMed ID: 1426099 [TBL] [Abstract][Full Text] [Related]
15. Low dose interleukin-2 following intensification therapy with high dose cytarabine for acute myelogenous leukemia in first complete remission. Stone RM; DeAngelo DJ; Janosova A; Galinsky I; Canning C; Ritz J; Soiffer RJ Am J Hematol; 2008 Oct; 83(10):771-7. PubMed ID: 18756547 [TBL] [Abstract][Full Text] [Related]
16. Results of treatment with an intensive combination induction regimen containing idarubicin in children with acute myeloblastic leukemia: preliminary report of the Argentine Group for Treatment of Acute Leukemia. Sackmann-Muriel F; Fernández-Barbieri MA; Santarelli MT; Matus-Ridley M; Rosso A; Negri-Aranguren P; Cerutti I; Gomel M; Kvicala R Semin Oncol; 1993 Dec; 20(6 Suppl 8):34-8. PubMed ID: 8290970 [TBL] [Abstract][Full Text] [Related]